Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086878786> ?p ?o ?g. }
- W2086878786 endingPage "438" @default.
- W2086878786 startingPage "433" @default.
- W2086878786 abstract "We have been developing prodrugs of anticancer agents such as 5-fluorouracil (5-FU) that are activated by irradiation under hypoxic conditions via one-electron reduction. Among them, OFU001 [1-(2′-oxopropyl)-5-fluorouracil] is a prototype radiation-activated prodrug. In this study, we investigated the radiation chemical reactivity and the biological effects of OFU001. This prodrug is presumed to release 5-FU through incorporation of hydrated electrons into the antibonding σ* orbital of the C(1′)-N(1) bond. Hydrated electrons are active species derived from radiolysis of water, but are readily deactivated by O2 into superoxide anion radicals () under conditions of aerobic irradiation. Therefore, 5-FU release occurs highly specifically upon irradiation under hypoxic conditions. OFU001 dissolved in phosphate buffer released 5-FU with a G-value (mol number of molecules that are decomposed or produced by 1 J of absorbed radiation energy) of 1.9×10−7 mol/ J following hypoxic irradiation, while the G-value for 5-FU release was 1.0×10−8 mol/J following aerobic irradiation. However, the G-values for decomposition of OFU001 were almost the same, i.e., 3.4×10−7 mol/J following hypoxic irradiation and 2.5×10−7 mol/J following aerobic irradiation. When hypoxically irradiated (7.5–30 Gy) OFU001 was added to murine SCCVII cells for 1–24 h, a significant cell-killing effect was observed. The degree of this cytotoxicity was consistent with that of authentic 5-FU at the corresponding concentrations. On the other hand, cytotoxicity was minimal when the cells were treated with aerobically irradiated or unirradiated OFU001. This compound had no radiosensitizing effect against SCCVII cells under either aerobic or hypoxic conditions when the drug was removed immediately after irradiation. Since hypoxia is generally most marked in tumors and irradiation is applied at the tumor site, this concept of prodrug design appears to be potentially useful for selective tumor treatment with minimal adverse effects of anticancer agents." @default.
- W2086878786 created "2016-06-24" @default.
- W2086878786 creator A5014787967 @default.
- W2086878786 creator A5046722952 @default.
- W2086878786 creator A5065869292 @default.
- W2086878786 creator A5071240286 @default.
- W2086878786 creator A5089437525 @default.
- W2086878786 date "2000-04-01" @default.
- W2086878786 modified "2023-10-17" @default.
- W2086878786 title "A Novel Class of Antitumor Prodrug, 1-(2′-Oxopropyl)-5-fluorouracil (OFU001), That Releases 5-Fluorouracil upon Hypoxic Irradiation" @default.
- W2086878786 cites W1481729114 @default.
- W2086878786 cites W1550628230 @default.
- W2086878786 cites W1980157221 @default.
- W2086878786 cites W1985049521 @default.
- W2086878786 cites W1994397468 @default.
- W2086878786 cites W1994555849 @default.
- W2086878786 cites W2043316231 @default.
- W2086878786 cites W2071628613 @default.
- W2086878786 cites W2086187998 @default.
- W2086878786 cites W2094458872 @default.
- W2086878786 cites W2097813123 @default.
- W2086878786 cites W2136817236 @default.
- W2086878786 cites W2138865276 @default.
- W2086878786 cites W2146509482 @default.
- W2086878786 cites W2169693919 @default.
- W2086878786 cites W2315902038 @default.
- W2086878786 cites W2950982166 @default.
- W2086878786 doi "https://doi.org/10.1111/j.1349-7006.2000.tb00963.x" @default.
- W2086878786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5926472" @default.
- W2086878786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10804292" @default.
- W2086878786 hasPublicationYear "2000" @default.
- W2086878786 type Work @default.
- W2086878786 sameAs 2086878786 @default.
- W2086878786 citedByCount "25" @default.
- W2086878786 countsByYear W20868787862015 @default.
- W2086878786 countsByYear W20868787862017 @default.
- W2086878786 countsByYear W20868787862018 @default.
- W2086878786 countsByYear W20868787862022 @default.
- W2086878786 countsByYear W20868787862023 @default.
- W2086878786 crossrefType "journal-article" @default.
- W2086878786 hasAuthorship W2086878786A5014787967 @default.
- W2086878786 hasAuthorship W2086878786A5046722952 @default.
- W2086878786 hasAuthorship W2086878786A5065869292 @default.
- W2086878786 hasAuthorship W2086878786A5071240286 @default.
- W2086878786 hasAuthorship W2086878786A5089437525 @default.
- W2086878786 hasBestOaLocation W20868787861 @default.
- W2086878786 hasConcept C108215921 @default.
- W2086878786 hasConcept C109316439 @default.
- W2086878786 hasConcept C111337013 @default.
- W2086878786 hasConcept C121332964 @default.
- W2086878786 hasConcept C139066938 @default.
- W2086878786 hasConcept C13965031 @default.
- W2086878786 hasConcept C155647269 @default.
- W2086878786 hasConcept C177322064 @default.
- W2086878786 hasConcept C185544564 @default.
- W2086878786 hasConcept C185592680 @default.
- W2086878786 hasConcept C202751555 @default.
- W2086878786 hasConcept C2776694085 @default.
- W2086878786 hasConcept C2780456651 @default.
- W2086878786 hasConcept C54355233 @default.
- W2086878786 hasConcept C55493867 @default.
- W2086878786 hasConcept C66887884 @default.
- W2086878786 hasConcept C71240020 @default.
- W2086878786 hasConcept C75473681 @default.
- W2086878786 hasConcept C86803240 @default.
- W2086878786 hasConceptScore W2086878786C108215921 @default.
- W2086878786 hasConceptScore W2086878786C109316439 @default.
- W2086878786 hasConceptScore W2086878786C111337013 @default.
- W2086878786 hasConceptScore W2086878786C121332964 @default.
- W2086878786 hasConceptScore W2086878786C139066938 @default.
- W2086878786 hasConceptScore W2086878786C13965031 @default.
- W2086878786 hasConceptScore W2086878786C155647269 @default.
- W2086878786 hasConceptScore W2086878786C177322064 @default.
- W2086878786 hasConceptScore W2086878786C185544564 @default.
- W2086878786 hasConceptScore W2086878786C185592680 @default.
- W2086878786 hasConceptScore W2086878786C202751555 @default.
- W2086878786 hasConceptScore W2086878786C2776694085 @default.
- W2086878786 hasConceptScore W2086878786C2780456651 @default.
- W2086878786 hasConceptScore W2086878786C54355233 @default.
- W2086878786 hasConceptScore W2086878786C55493867 @default.
- W2086878786 hasConceptScore W2086878786C66887884 @default.
- W2086878786 hasConceptScore W2086878786C71240020 @default.
- W2086878786 hasConceptScore W2086878786C75473681 @default.
- W2086878786 hasConceptScore W2086878786C86803240 @default.
- W2086878786 hasIssue "4" @default.
- W2086878786 hasLocation W20868787861 @default.
- W2086878786 hasLocation W20868787862 @default.
- W2086878786 hasLocation W20868787863 @default.
- W2086878786 hasLocation W20868787864 @default.
- W2086878786 hasOpenAccess W2086878786 @default.
- W2086878786 hasPrimaryLocation W20868787861 @default.
- W2086878786 hasRelatedWork W130229104 @default.
- W2086878786 hasRelatedWork W1974416061 @default.
- W2086878786 hasRelatedWork W2006549952 @default.
- W2086878786 hasRelatedWork W2017524426 @default.
- W2086878786 hasRelatedWork W2058986864 @default.
- W2086878786 hasRelatedWork W2062163549 @default.
- W2086878786 hasRelatedWork W2075267158 @default.